@article{article, title  = {{Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial}},

 publisher = {{Elsevier BV}},

 url = {{https://doi.org/10.1016/s0140-6736(25)00262-4 }},

 year = {{2025}},

 month = {{5}},

 author = {{Bensimon G and Leigh PN and Tree T and Malaspina A and Payan CAM and Pham H-P and Klaassen P and Shaw PJ and Al Khleifat A and Amador MDM and Attarian S et al}},

 doi = {{10.1016/s0140-6736(25)00262-4}},

 journal = {{The Lancet}},

 note = {{Accessed on 2025/06/07}}}